Renewal of authorization for genetically modified maize MON 89034 × 1507 × NK603

The European Parliament has examined the renewal of authorization for genetically modified maize MON 89034 × 1507 × NK603. This decision comes in the context of safety assessments and concerns about environmental and health impacts. The text addresses producers, importers, and consumers in the European Union.

Context and objectives

The legal basis is Regulation (EC) No 1829/2003 on genetically modified food and feed. The objective is to ensure that products containing this genetically modified maize meet safety standards for human health, animal health, and the environment. The procedure involves assessment by the European Food Safety Authority (EFSA) and consultation with Member States.

Key measures

• Renewal of marketing authorization for genetically modified maize MON 89034 × 1507 × NK603
• Compliance with risk assessment procedures established by European legislation
• Consideration of Member States' opinions and scientific observations
• Ensuring transparency in the authorization process
• Monitoring impact on environment and health

Timeline and implementation

The authorization decision was adopted in 2024 following EFSA's assessment in March 2024. The European Commission is responsible for implementation, and Member States must ensure compliance with authorization conditions. Control is carried out through existing GMO monitoring mechanisms on the European market.

Impact for citizens and stakeholders

Farmers growing this maize benefit from its herbicide tolerance and insecticidal properties. Consumers have access to products assessed as safe by EFSA. Points of attention include potential impact on biodiversity and the need for continuous monitoring of combined effects of Bt toxins and herbicide residues.